Literature DB >> 19022751

Induced pluripotency of mouse and human somatic cells.

N Maherali1, K Hochedlinger.   

Abstract

The identification of transcription factors to induce pluripotency directly in somatic cells has given researchers a unique platform on which to dissect the mechanisms underlying epigenetic reprogramming. In addition, induced pluripotent stem (iPS) cells have enabled the derivation of patient-specific cells for the study and potential treatment of a variety of diseases. Here, we discuss recent discoveries in the reprogramming field including work from our own laboratory.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 19022751     DOI: 10.1101/sqb.2008.73.017

Source DB:  PubMed          Journal:  Cold Spring Harb Symp Quant Biol        ISSN: 0091-7451


  11 in total

Review 1.  Diabetes mellitus and the skin.

Authors:  E Makrantonaki; D Jiang; A M Hossini; G Nikolakis; M Wlaschek; K Scharffetter-Kochanek; C C Zouboulis
Journal:  Rev Endocr Metab Disord       Date:  2016-09       Impact factor: 6.514

2.  Generation of induced pluripotent stem cells using site-specific integration with phage integrase.

Authors:  Lin Ye; Judy C Chang; Chin Lin; Zhongxia Qi; Jingwei Yu; Yuet Wai Kan
Journal:  Proc Natl Acad Sci U S A       Date:  2010-10-25       Impact factor: 11.205

3.  Reduce, reuse, reprogram.

Authors:  Thomas P Zwaka
Journal:  Nat Methods       Date:  2010-01       Impact factor: 28.547

4.  Amniotic fluid cells are more efficiently reprogrammed to pluripotency than adult cells.

Authors:  Elisa Galende; Ioannis Karakikes; Lisa Edelmann; Robert J Desnick; Thomas Kerenyi; Georges Khoueiry; James Lafferty; Joseph T McGinn; Michael Brodman; Valentin Fuster; Roger J Hajjar; Katalin Polgar
Journal:  Cell Reprogram       Date:  2010-04       Impact factor: 1.987

5.  The prospect of induced pluripotent stem cells for diabetes mellitus treatment.

Authors:  Andreas Soejitno; Pande Kadek Aditya Prayudi
Journal:  Ther Adv Endocrinol Metab       Date:  2011-10       Impact factor: 3.565

6.  Molecular analyses of human induced pluripotent stem cells and embryonic stem cells.

Authors:  Mark H Chin; Matteo Pellegrini; Kathrin Plath; William E Lowry
Journal:  Cell Stem Cell       Date:  2010-08-06       Impact factor: 24.633

7.  Embryoid body formation of human amniotic fluid stem cells depends on mTOR.

Authors:  A Valli; M Rosner; C Fuchs; N Siegel; C E Bishop; H Dolznig; U Mädel; W Feichtinger; A Atala; M Hengstschläger
Journal:  Oncogene       Date:  2009-11-23       Impact factor: 9.867

8.  Directed differentiation of progenitor cells towards an islet-cell phenotype.

Authors:  Arif Abed; Charlotte Critchlow; Peter R Flatt; Neville H McClenaghan; Catriona Kelly
Journal:  Am J Stem Cells       Date:  2012-11-30

9.  Stem cell-based approaches for the treatment of diabetes.

Authors:  Catriona Kelly; Cara C S Flatt; Neville H McClenaghan
Journal:  Stem Cells Int       Date:  2011-05-18       Impact factor: 5.443

Review 10.  Diabetes treatment: A rapid review of the current and future scope of stem cell research.

Authors:  Sheriff Sheik Abdulazeez
Journal:  Saudi Pharm J       Date:  2013-12-24       Impact factor: 4.330

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.